Atlas Trials

A Relative Bioavailability Study of HRS9531 in Healthy Subjects

Clinical trial NCT05893576 · COMPLETED

Trial details

NCT number
NCT05893576
Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2023-05-15
Primary completion
2023-09-04
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.